Earlier diagnostic screening, routine and emerging therapies, and increased awareness are helping people with the lysosomal storage disorder Fabry disease lead a longer, healthier life.
Use of a remote electrical neuromodulation device every other day helped patients significantly reduce their number of migraine days compared with a placebo device, in new research.
Experts discuss the history of rofecoxib, including its market withdrawal and subsequent resurrection. The once-bestselling painkiller known as Vioxx is now proceeding to a phase 3 trial for migraine.
While the United Council for Neurologic Subspecialties says the switch to continuous certification was done to keep up with new standards, many physicians are frustrated with its execution.